Product record
Glipizide Metformin: batches declared Not of Standard Quality
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026
3 batches of products named "Glipizide Metformin" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between June 2024 and December 2025. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
3 records linked to Glipizide Metformin in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| URDT0328Mfg 2023-01 · Exp 2025-12 | Unicure India LtdUttarakhand | The sample does not conform to the IP with respect to Dissolution of Glipizide.Dissolution | DTL UdaipurState lab | Dec 2025 |
| Z24-011Mfg 2024-01 · Exp 2026-12 | Zee Laboratories LtdHimachal Pradesh | DescriptionDescription | CDTL IndoreCDSCO lab | Jun 2025 |
| 4010026Mfg 2023-11 · Exp 2025-04 | USV Private LimitedKarnataka | Dissolution of GlipizideDissolution | CDL KolkataCDSCO lab | Jun 2024 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.